Nicole M Kuderer
Overview
Explore the profile of Nicole M Kuderer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
7307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Menz B, Kuderer N, Chin-Yee B, Logan J, Rowland A, Sorich M, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2434997.
PMID: 39312237
Importance: With the growing use of large language models (LLMs) in education and health care settings, it is important to ensure that the information they generate is diverse and equitable,...
3.
4.
Modi N, Swain S, Buyse M, Kuderer N, Rowland A, Rockhold F, et al.
J Clin Oncol
. 2024 Jun;
42(32):3773-3777.
PMID: 38917375
Unlocking the full potential of clinical trials through comprehensive CSR and IPD sharing can revolutionize cancer care, enhance safety evaluations, and reduce bias in systematic reviews. It is time for...
5.
Atre S, Soulos P, Kuderer N, Gross C, Baum L, Dinan M, et al.
Breast Cancer Res Treat
. 2024 May;
207(3):541-550.
PMID: 38816556
Purpose: Recognizing that receiving healthcare can be time intensive and burdensome, time toxicity has been conceptualized as the time spent by patients seeking healthcare. This study investigates the association between...
6.
7.
8.
Banerjee R, Cowan A, Ortega M, Missimer C, Carpenter P, Ueda Oshima M, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Mar;
24(7):446-454.e3.
PMID: 38521640
Background: Patients with multiple myeloma (MM) may be on therapy for years, which can lead to financial toxicity (FinTox) or time toxicity (TimeTox). The prevalence, predictors, and quality of life...
9.
Menz B, Kuderer N, Bacchi S, Modi N, Chin-Yee B, Hu T, et al.
BMJ
. 2024 Mar;
384:e078538.
PMID: 38508682
Objectives: To evaluate the effectiveness of safeguards to prevent large language models (LLMs) from being misused to generate health disinformation, and to evaluate the transparency of artificial intelligence (AI) developers...
10.
Lyman G, Lyman C, Kuderer N
Cancer Invest
. 2024 Feb;
42(5):361-364.
PMID: 38303557
No abstract available.